Lineage Cell Therapeutics, Inc. Soared

Mon, May 03, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. Soared

Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) soared at $78.5, a gain of 57.6%. On Fri, Apr 30, 2021, BTX:NYSEMKT hit a New 2-Week High of $49.8. The stock appeared on our News Catalysts scanner on Thu, Apr 29, 2021 at 10:01 AM in the 'BIOTECH' category. From Fri, Apr 16, 2021, the stock recorded 70.00% Up Days and 72.73% Green Days

About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)

BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.